Breath volatile organic compounds and inflammatory markers in adult asthma patients: negative results from the ALLIANCE cohort

Eur Respir J. 2021 Feb 11;57(2):2002127. doi: 10.1183/13993003.02127-2020. Print 2021 Feb.

Abstract

Despite recent publications, we are not close to finding a clinically valuable breath VOC biomarker for asthma or asthma phenotypes https://bit.ly/3heTgtK

Trial registration: ClinicalTrials.gov NCT02419274.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Asthma*
  • Biomarkers
  • Breath Tests
  • Exhalation
  • Humans
  • Negative Results
  • Volatile Organic Compounds*

Substances

  • Biomarkers
  • Volatile Organic Compounds

Associated data

  • ClinicalTrials.gov/NCT02419274